BIOMAT Database Logo BIOMAT Database Logo

Difluoromethylbenzoxazole pyrimidine thioether derivatives: a novel class of potent non-nucleoside HIV-1 reverse transcriptase inhibitors. 2011

Jérémie Boyer, and Eric Arnoult, and Maurice Médebielle, and Jérôme Guillemont, and Johan Unge, and Dirk Jochmans
Université de Lyon, Université Claude Bernard Lyon 1, Institut de Chimie et Biochimie Moléculaires et Supramoléculaires, UMR CNRS-UCBL-INSA, Equipe Synthèse de Molécules d'Intérêt Thérapeutique, Bâtiment Curien, 43 Boulevard du 11 Novembre 1918, F-69622 Villeurbanne, France.

This paper reports the synthesis and antiviral properties of new difluoromethylbenzoxazole (DFMB) pyrimidine thioether derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors. By use of a combination of structural biology study and traditional medicinal chemistry, several members of this novel class were synthesized using a single electron transfer chain process (radical nucleophilic substitution, S(RN)1) and were found to be potent against wild-type HIV-1 reverse transcriptase, with low cytotoxicity but with moderate activity against drug-resistant strains. The most promising compound 24 showed a significant EC(50) value close to 6.4 nM against HIV-1 IIIB, a moderate EC(50) value close to 54 μM against an NNRTI resistant double mutant (K103N + Y181C), but an excellent selectivity index >15477 (CC(50) > 100 μM).

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001583 Benzoxazoles Benzoxazole
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013440 Sulfides Chemical groups containing the covalent sulfur bonds -S-. The sulfur atom can be bound to inorganic or organic moieties. Sulfide,Thioether,Thioethers,Sulfur Ethers,Ethers, Sulfur
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse

Related Publications

Jérémie Boyer, and Eric Arnoult, and Maurice Médebielle, and Jérôme Guillemont, and Johan Unge, and Dirk Jochmans
1,2,3-Thiadiazole thioacetanilides as a novel class of potent HIV-1 non-nucleoside reverse transcriptase inhibitors.
October 2008, Bioorganic & medicinal chemistry letters,
Jérémie Boyer, and Eric Arnoult, and Maurice Médebielle, and Jérôme Guillemont, and Johan Unge, and Dirk Jochmans
Diarylaniline derivatives as a distinct class of HIV-1 non-nucleoside reverse transcriptase inhibitors.
July 2010, Journal of medicinal chemistry,
Jérémie Boyer, and Eric Arnoult, and Maurice Médebielle, and Jérôme Guillemont, and Johan Unge, and Dirk Jochmans
Discovery of Phenylaminopyridine Derivatives as Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors.
August 2012, ACS medicinal chemistry letters,
Jérémie Boyer, and Eric Arnoult, and Maurice Médebielle, and Jérôme Guillemont, and Johan Unge, and Dirk Jochmans
Discovery of diarylpyridine derivatives as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.
September 2009, Bioorganic & medicinal chemistry letters,
Jérémie Boyer, and Eric Arnoult, and Maurice Médebielle, and Jérôme Guillemont, and Johan Unge, and Dirk Jochmans
Pharmacophore-fusing design of pyrimidine sulfonylacetanilides as potent non-nucleoside inhibitors of HIV-1 reverse transcriptase.
March 2020, Bioorganic chemistry,
Jérémie Boyer, and Eric Arnoult, and Maurice Médebielle, and Jérôme Guillemont, and Johan Unge, and Dirk Jochmans
2,4,5-Trisubstituted thiazole derivatives: a novel and potent class of non-nucleoside inhibitors of wild type and mutant HIV-1 reverse transcriptase.
October 2014, European journal of medicinal chemistry,
Jérémie Boyer, and Eric Arnoult, and Maurice Médebielle, and Jérôme Guillemont, and Johan Unge, and Dirk Jochmans
Novel piperidinylamino-diarylpyrimidine derivatives with dual structural conformations as potent HIV-1 non-nucleoside reverse transcriptase inhibitors.
December 2013, Bioorganic & medicinal chemistry letters,
Jérémie Boyer, and Eric Arnoult, and Maurice Médebielle, and Jérôme Guillemont, and Johan Unge, and Dirk Jochmans
Novel Cyclopropyl-Indole Derivatives as HIV Non-Nucleoside Reverse Transcriptase Inhibitors.
June 2012, ACS medicinal chemistry letters,
Jérémie Boyer, and Eric Arnoult, and Maurice Médebielle, and Jérôme Guillemont, and Johan Unge, and Dirk Jochmans
Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors: A Combinatorial Approach.
December 2017, Biochemistry. Biokhimiia,
Jérémie Boyer, and Eric Arnoult, and Maurice Médebielle, and Jérôme Guillemont, and Johan Unge, and Dirk Jochmans
Rational design of potent non-nucleoside inhibitors of HIV-1 reverse transcriptase.
December 2012, Journal of medicinal chemistry,
Copied contents to your clipboard!